caffeine citrate has been researched along with Infant, Premature, Diseases in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (15.56) | 18.7374 |
| 1990's | 2 (4.44) | 18.2507 |
| 2000's | 6 (13.33) | 29.6817 |
| 2010's | 15 (33.33) | 24.3611 |
| 2020's | 15 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, J; Wei, Y; Xin, Y; Zheng, R | 1 |
| Jiang, H; Li, Y; Liu, W; Miao, Y; Wang, A; Zhang, Y; Zhao, S; Zhou, Y | 1 |
| Brattström, P; Bruschettini, M; Davis, PG; Onland, W; Russo, C; Soll, R | 1 |
| Clark, RH; Greenberg, RG; Ji, D; Ku, L; Laughon, M; Smith, PB; Zimmerman, KO | 1 |
| Bor, M; Ilhan, O | 1 |
| Ding, Y; Gan, JM; He, T; Li, W; Liao, ZC; Wang, MJ; Yue, SJ | 1 |
| Di, X; Fan, J; Guo, A; Hu, X; Huang, L; Xie, H; Xue, J; Zhao, P; Zhu, Z | 1 |
| Grunau, RE; Synnes, A | 1 |
| Cheong, JLY; Doyle, LW | 1 |
| Davis, PG | 1 |
| Patel, RM; Saroha, V | 1 |
| Eichenwald, EC | 1 |
| Ayede, AI; Ekhaguere, OA; Ezeaka, CV | 1 |
| Zupancic, JAF | 1 |
| Aranda, JV; Beharry, KD | 1 |
| Anderson, PJ; Asztalos, EV; Costantini, L; D'Ilario, J; Davis, PG; Dewey, D; Doyle, LW; Grunau, RE; Moddemann, D; Nelson, H; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W | 1 |
| Corwin, MJ; Darnall, RA; Dobson, NR; Eichenwald, E; Heeren, TC; Hunt, CE; James, LP; McEntire, BL; Rhein, LM | 1 |
| deRegnier, RA | 1 |
| Datta, AN; Jost, K; Koch, G; Pfister, M; Schulzke, SM; van den Anker, J | 1 |
| Askenazi, DJ; Boohaker, LJ; Carmody, JB; Charlton, JR; Griffin, RL; Guillet, R; Harer, MW; Selewski, DT; Swanson, JR | 1 |
| Bendel-Stenzel, E; Chhabra, R; Harper, B; Ku, L; Laughon, M; Moya, F; Payne, EH; Puia-Dumitrescu, M; Smith, PB; Soriano, A; Wade, KC; Zhao, J | 1 |
| Chawla, R; Haloi, P; Kumar, M; Singh, M | 1 |
| Arand, J; Engel, C; Poets, CF; Vatlach, S | 1 |
| Schoen, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Yu, T | 1 |
| Abdel-Hady, H; Mohammed, S; Nasef, N; Nour, I; Shabaan, AE; Shouman, B | 1 |
| Liu, G; Tian, X; Zhao, Y | 1 |
| Carnielli, VP; Fabbri, L; Ferrari, F; Kiechl-Kohlendorfer, U; Lasagna, G; Lista, G; Papagaroufalis, K; Polackova, R; Saenz, P | 1 |
| Bin-Nun, A; Ionchev, A; Meadow, W; Soloveychik, V; Sriram, S | 1 |
| El Ayoubi, M; Lescure, S; Lopez, E; Moriette, G | 1 |
| Duman, N; Kumral, A; Ozkan, H; Tuzun, F; Yesilirmak, DC | 1 |
| Bedetta, M; Paolillo, P; Picone, S | 1 |
| Baudon, JJ; Biran-Mucignat, V; Ducrocq, S; Gold, F; Lebas, F | 1 |
| Baudon, JJ; Biran-Mucignat, V; Boelle, PY; Ducrocq, S; Gold, F; Lebas, F | 1 |
| Barrington, KJ; Davis, P; Doyle, LW; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W | 1 |
| Brendstrup, L; Flachs, H; Larsen, PB; Skov, L | 1 |
| Bucher, HU; Duc, G | 2 |
| DeCristofaro, JD; Katz, S; Subhani, M | 1 |
| Gannon, BA | 1 |
| Flood, E | 1 |
| Noerr, B | 1 |
| Bonte, JB; Debruyne, D; Lacotte, J; Laloum, D; Moulin, M; Perrin, C | 1 |
| Anwar, M; Graff, M; Hegyi, T; Hiatt, M; Mojica, N; Mondestin, H; Novo, R | 1 |
| Bucher, HU; Duc, G; Fallenstein, F; Mieth, D | 1 |
| Billon, B; Le Guennec, JC; Paré, C | 1 |
10 review(s) available for caffeine citrate and Infant, Premature, Diseases
| Article | Year |
|---|---|
Comparative efficacy and safety of caffeine citrate and aminophylline in treating apnea of prematurity: A systematic review and meta-analysis.
Topics: Aminophylline; Apnea; Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases | 2022 |
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Child; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases | 2023 |
Neurodevelopmental outcomes after neonatal caffeine therapy.
Topics: Animals; Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; Developmental Disabilities; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Neurodevelopmental Disorders | 2020 |
Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Cerebral Hemorrhage; Citrates; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases | 2020 |
National and international guidelines for neonatal caffeine use: Are they evidenced-based?
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Evidence-Based Medicine; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Observational Studies as Topic | 2020 |
Cost-effectiveness and pricing of caffeine.
Topics: Caffeine; Citrates; Cost Control; Cost-Benefit Analysis; Drug Costs; Humans; Infant, Newborn; Infant, Premature, Diseases; Prescription Drugs | 2020 |
Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Drug Monitoring; Humans; Infant, Premature; Infant, Premature, Diseases; Randomized Controlled Trials as Topic; Theophylline | 2014 |
[Apnea of prematurity: what's new?].
Topics: Apnea; Bradycardia; Brain Damage, Chronic; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrates; Combined Modality Therapy; Continuous Positive Airway Pressure; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Neonatal Screening; Oxygen; Risk Factors | 2010 |
Caffeine citrate: when and for how long. A literature review.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Humans; Infant, Newborn; Infant, Premature, Diseases | 2012 |
Theophylline or caffeine: which is best for apnea of prematurity?
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Theophylline; Treatment Outcome | 2000 |
8 trial(s) available for caffeine citrate and Infant, Premature, Diseases
| Article | Year |
|---|---|
[Comparison of the efficacy of domestic and imported caffeine citrate in the treatment of apnea in preterm infants: a prospective randomized double-blind controlled trial].
Topics: Apnea; Caffeine; Citrates; Double-Blind Method; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Prospective Studies | 2020 |
Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Child Behavior Disorders; Child Development; Citrates; Developmental Disabilities; Double-Blind Method; Educational Status; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Motor Disorders | 2017 |
High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
Topics: Airway Extubation; Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Double-Blind Method; Egypt; Female; Hospital Mortality; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pilot Projects; Prospective Studies; Respiration, Artificial; Tachycardia | 2015 |
[Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
Topics: Apnea; Birth Weight; Caffeine; Citrates; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pregnancy; Treatment Outcome | 2016 |
Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity.
Topics: Bronchopulmonary Dysplasia; Caffeine; Case-Control Studies; Citrates; Drug Administration Schedule; Genetic Markers; Genotype; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Logistic Models; Polymorphism, Single Nucleotide; Prospective Studies; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A1; Receptors, Adenosine A2; Sleep Apnea Syndromes; Treatment Outcome | 2012 |
Long-term effects of caffeine therapy for apnea of prematurity.
Topics: Apnea; Body Size; Caffeine; Central Nervous System Stimulants; Cerebral Palsy; Citrates; Developmental Disabilities; Epilepsy; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Logistic Models; Male; Odds Ratio; Retinopathy of Prematurity; Survival Rate | 2007 |
Aminophylline versus caffeine citrate for apnea and bradycardia prophylaxis in premature neonates.
Topics: Apnea; Bradycardia; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases; Theophylline | 1995 |
Does caffeine prevent hypoxaemic episodes in premature infants? A randomized controlled trial.
Topics: Blood Gas Monitoring, Transcutaneous; Bradycardia; Caffeine; Citrates; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hypoxia; Infant, Newborn; Infant, Premature, Diseases; Male; Random Allocation; Recurrence | 1988 |
27 other study(ies) available for caffeine citrate and Infant, Premature, Diseases
| Article | Year |
|---|---|
Effects of caffeine citrate on respiratory mechanics and pulmonary function during peri-extubation in premature infants with low body weight.
Topics: Airway Extubation; Body Weight; Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Respiratory Mechanics | 2022 |
Wide variation in caffeine discontinuation timing in premature infants.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Cohort Studies; Combined Modality Therapy; Drug Administration Schedule; Female; Hospitalization; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Positive-Pressure Respiration; Respiration | 2020 |
Effects of Single Loading Dose of Intravenous Caffeine on Cerebral Oxygenation in Preterm Infants.
Topics: Brain; Caffeine; Citrates; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infusions, Intravenous; Male; Oxygen; Oxygen Saturation; Prospective Studies; Spectroscopy, Near-Infrared | 2021 |
Population pharmacokinetic study of caffeine citrate in Chinese premature infants with apnea.
Topics: Apnea; Asian People; Caffeine; Central Nervous System Stimulants; Citrates; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Models, Biological; Nonlinear Dynamics; Retrospective Studies | 2020 |
Childhood respiratory outcomes after neonatal caffeine therapy.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Child; Citrates; Ductus Arteriosus, Patent; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Oxygen Inhalation Therapy | 2020 |
When to start and stop caffeine and why respiratory status matters.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Humans; Hypoxia; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Randomized Controlled Trials as Topic; Respiration, Artificial | 2020 |
Is caffeine available and affordable in low and middle-income countries? A survey in sub-Saharan Africa.
Topics: Africa South of the Sahara; Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Costs and Cost Analysis; Developing Countries; Health Services Accessibility; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Pharmaceutical Preparations; World Health Organization | 2020 |
Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal | 2020 |
Caffeine decreases intermittent hypoxia in preterm infants nearing term-equivalent age.
Topics: Adult; Caffeine; Case-Control Studies; Central Nervous System Stimulants; Citrates; Drug Administration Schedule; Female; Gestational Age; Humans; Hypoxia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Oximetry; Prospective Studies | 2017 |
Dosing wisely: caffeine and the preterm infant.
Topics: Caffeine; Citrates; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases | 2017 |
Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Weight Gain | 2017 |
Association Between Early Caffeine Citrate Administration and Risk of Acute Kidney Injury in Preterm Neonates: Results From the AWAKEN Study.
Topics: Acute Kidney Injury; Caffeine; Citrates; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Internationality; Male; Renal Agents; Retrospective Studies | 2018 |
Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Cerebral Hemorrhage; Citrates; Ductus Arteriosus, Patent; Electronic Health Records; Enterocolitis, Necrotizing; Female; Gestational Age; Humans; Infant, Extremely Premature; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Intensive Care, Neonatal; Male; Multivariate Analysis; Off-Label Use; Treatment Outcome | 2019 |
The use of caffeine for the treatment of apnea of prematurity and bradycardia in a holoprosencephalic child with cleft lip and palate.
Topics: Apnea; Bradycardia; Caffeine; Central Nervous System Stimulants; Citrates; Cleft Lip; Cleft Palate; Female; Holoprosencephaly; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Postoperative Complications | 2013 |
Safety profile comparison between extemporaneous and a licensed preparation of caffeine citrate in preterm infants with apnea of prematurity.
Topics: Apnea; Caffeine; Chemistry, Pharmaceutical; Citrates; Drug-Related Side Effects and Adverse Reactions; Female; Germany; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Licensure; Longitudinal Studies; Male | 2014 |
The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Citrates; Europe; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Product Surveillance, Postmarketing | 2016 |
Acute hemodynamic effects of caffeine administration in premature infants.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Prospective Studies | 2009 |
[Caffeine citrate utilization for treatment of apnea in French neonatal units].
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; France; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Surveys and Questionnaires | 2006 |
[Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate].
Topics: Ambulatory Care; Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Citrates; Continuous Positive Airway Pressure; Female; Gastroesophageal Reflux; Humans; Hypotension; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Multivariate Analysis; Pregnancy; Pregnancy, Multiple; Retrospective Studies; Risk Factors | 2006 |
Aminophylline versus caffeine citrate...
Topics: Aminophylline; Apnea; Bradycardia; Caffeine; Cardiotonic Agents; Citrates; Clinical Trials as Topic; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases; Placebos; Research Design | 1995 |
Prediction of postdischarge complications by predischarge event recordings in infants with apnea of prematurity.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Monitoring, Ambulatory; Predictive Value of Tests | 2000 |
Caffeine citrate in the NICU.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal | 1989 |
Caffeine citrate. Pointers in practical pharmacology.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases | 1989 |
Treatment of caffeine intoxication by exchange transfusion in a newborn.
Topics: Acute Disease; Caffeine; Citrates; Drug Combinations; Exchange Transfusion, Whole Blood; Humans; Infant, Newborn; Infant, Premature, Diseases; Male | 1987 |
Effect of caffeine on pneumogram and apnoea of infancy.
Topics: Apnea; Caffeine; Citrates; Drug Combinations; Humans; Infant, Newborn; Infant, Premature, Diseases; Respiration; Time Factors | 1986 |
[Effectiveness of low- and high-dose caffeine on idiopathic bradycardia and hypoxemia in premature infants].
Topics: Bradycardia; Caffeine; Citrates; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypoxia; Infant, Newborn; Infant, Premature, Diseases | 1985 |
Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding.
Topics: Aging; Apnea; Breast Feeding; Caffeine; Cholestasis; Citrates; Drug Combinations; Gestational Age; Half-Life; Hepatitis; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Liver; Longitudinal Studies; Prospective Studies | 1985 |